Paul Hudson (businessman)
This article or section is in a state of significant expansion or restructuring. You are welcome to assist in its construction by editing it as well. If this article or section has not been edited in several days, please remove this template. If you are the editor who added this template and you are actively editing, please be sure to replace this template with {{in use}} during the active editing session. Click on the link for template parameters to use.
This article was last edited by Mike Peel (talk | contribs) 3 years ago. (Update timer) |
Paul Hudson | |
---|---|
Born | [1] | October 14, 1967
Nationality | British |
Education | Manchester Metropolitan University |
Title | CEO, Sanofi |
Predecessor | Olivier Brandicourt |
Children | 3 |
Paul Hudson (born 14 October 1967[2]) is a British businessman, and the chief executive (CEO) of Sanofi, the world's fifth largest pharmaceutical company by prescription drug sales.[3]
Early life
Hudson earned a degree in economics from Manchester Metropolitan University, and a diploma in marketing from the Chartered Institute of Marketing.[1]
Career
Hudson has been CEO of Sanofi since September 2019.[4][5][6]
Hudson was previously CEO of Novartis Pharmaceuticals, and before that AstraZeneca, rising to President, AstraZeneca United States and Executive Vice President, North America.[6]
Recognition
Hudson was awarded an honorary doctorate by Manchester Metropolitan University in 2018.[1]
Personal life
Hudson has three children and is an "ardent Manchester United football fan".[1]
References
- ^ a b c d "Paul Hudson - Sanofi". www.sanofi.com.
- ^ "Paul Hudson - Sanofi". www.sanofi.com. Retrieved 29 January 2021.
- ^ Willsher, Kim (26 January 2021). "French self-esteem hit after Pasteur Institute abandons Covid vaccine" – via www.theguardian.com.
- ^ "Sanofi CEO sees Big Pharma collaborating more even after a COVID vaccine is approved". Fortune.
- ^ "Sanofi's CEO on a big acquisition, long-term strategy, and vaccines". 17 August 2020.
- ^ a b "Global Proof of Concept: Q&A with Paul Hudson | Thought Leadership". Russell Reynolds Associates.